Does body mass index influence the decline of glomerular filtration rate in diabetic type 2 patients with diabetic nephropathy in a developing country?

References

• Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA. 2004;291:844–850
   PubMed Web of Science ®Google Scholar
• US Renal Data System. USRDS 2011 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2011
   Google Scholar
• US Renal Data System. USRDS 2003 Annual Data Report: Atlas of End Stage Renal Disease in the United States. Bethesda, MD: National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2003
   Google Scholar
• United States Renal Data System. USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End Stage Renal Disease in the United States. Bethesda, MD: National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2009
   Google Scholar
• Matsushita K, van der Velde M, Astor BC, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375:2073–2081
   PubMed Web of Science ®Google Scholar
• van der Velde M, Matsushita K, Coresh J, et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int. 2011;79:1341–1352
   PubMed Web of Science ®Google Scholar
• Gansevoort RT, Matsushita K, van der Velde M, et al. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes in both general and high-risk populations. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int. 2011;80:93–104
   PubMed Web of Science ®Google Scholar
• Astor BC, Matsushita K, Gansevoort RT, et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int. 2011;79:1331–1340
   PubMed Web of Science ®Google Scholar
• Tonelli M, Muntner P, Lloyd A, et al. Using proteinuria and estimated glomerular filtration rate to classify risk in patients with chronic kidney disease:a cohort study. Ann Intern Med. 2011;154:12–21
   PubMed Web of Science ®Google Scholar
• Pavlok ME, Knowler WC, Hanson RL, Benett PH, Nelson RG. Predictive power of sequential measures of albuminuria for progression to ESRD or Death in Pima Indians with type 2 diabetes. Am J Kidney Dis. 2008;51:759–766
   PubMedGoogle Scholar
• Imai E, Horio M, Yamagatha K, et al. Slower decline of glomerular filtration rate in the Japanese general population:a longitudinal 10 years follow up study. Hypertens Res. 2008;31:433–441
   PubMed Web of Science ®Google Scholar
• Praga M. Obesity—a neglected culprit in renal disease. Nephrol Dial Transplant. 2002;17:1157–1159
   PubMedGoogle Scholar
• Hall JE, Henegar JR, Dwyer TM, et al. Is obesity a major cause of chronic kidney disease? Adv Ren Replace Ther. 2004;11:41–54
   PubMedGoogle Scholar
• Ejerblad E, Fored CM, Lindblad P, Fryzek J, McLaughlin JK, Nyren O. Obesity and risk for chronic renal failure. J Am Soc Nephrol. 2006;17:1695–1702
   PubMed Web of Science ®Google Scholar
• Cignarelli M, Lamacchia O. Obesity and kidney disease. Nutr Metab Cardiovasc Dis. 2007;17:757–762
   PubMed Web of Science ®Google Scholar
• Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006;144:21–28
   PubMed Web of Science ®Google Scholar
• Iseki K, Ikemiya Y, Kinjo K, et al. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int. 2004;65:1870–1876
   PubMed Web of Science ®Google Scholar
• Hsu CY, Iribarren C, McCulloch CE, Darbinian J, Go AS. Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med. 2009;169(4):342–350
   PubMed Web of Science ®Google Scholar
• Ibrahim A, Arogundade FA, Sanusi AA, Ikem R, Akintomide AO, Akinsola AA. Which factors actually influence the development and progression of overt nephropathy in Nigerian diabetics? Cent Afr J Med. 2009;55(5-8):28–34
   PubMedGoogle Scholar
• KDOQI. Clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease: 2012 update. Am J Kidney Dis. 2013;61(6):1049
   Google Scholar
• Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Eknoyan G; National Kidney Foundation. National Kidney Foundation practice quinines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139:137–147
   Google Scholar
• Levey AS, Coresh J, Greene T, et al. Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem. 2007;53:766–772
   PubMed Web of Science ®Google Scholar
• Homish GG, Edwards EP, Eiden RD, Leonard KE. Analysing Family data: a GEE approach for substance use researchers. Addict Behav. 2010;35:558–563
   PubMed Web of Science ®Google Scholar
• Meigs JB, Wilson PW, Fox CS, et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardio vascular disease. J Clin Endocrinol Metab. 2006;91:2906–2912
   PubMed Web of Science ®Google Scholar
• Wannamethee SG, Shaper AG, Walker M. Overweight and obesity and weight change in middle aged men:impact on cardiovascular disease and diabetes. J Epidemiol Community Health. 2005;59:134–139
   PubMed Web of Science ®Google Scholar
• Brown R, Mohsen A, Gren D, et al. Body mass index has no effect on rate of progression of chronic kidney disease in non diabetic subjects. Nephrol Dial Transplant. 2012;27:2776–2780
   PubMedGoogle Scholar
• Khedr A, Khedr E, House AA. Body Mass Index of progression of chronic kidney disease. J Renal Nutr. 2011;21(6):455–461
   PubMedGoogle Scholar
• Othman M, Kawar B, El Nahas AM. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study. Nephron Clinical Practice. 2009;113:16–23
   Google Scholar
• Mohsen A, Brown R, Hoefield R, Kaira PA, O'Donoghue D, New DI. Body mass index has no effect on rate of progression of chronic kidney disease in subjects with type 2 diabetes mellitus. J Nephrol. 2012;25(3):384–393
   PubMedGoogle Scholar
• Ibrahim A, Arogundade FA, Sanusi AA, Ikem R, Akintomide AO, Akinsola AA. Which factors actually influence the development and progression of overt nephropathy in Nigerian diabetics? Cent Afr J Med. 2009;55:28–34
   PubMedGoogle Scholar
• Viswanathan V, Tilak P, S Kumpatla S. Risk Factors associated with the development of overt nephropathy in type 2 diabetes patients: a 12 years observational study. Indian J Med Res. 2012;136:46–53
   PubMed Web of Science ®Google Scholar
• Pavkov ME, Knowler WC, Lemley KV, Mason CC, Myers BD, Nelson RG. Early renal function decline in type 2 diabetes. Clin J Am Soc Nephrol. 2012;7:78–84
   PubMedGoogle Scholar
• Stengel B, Tarver-Carr ME, Powe NR, Eberhardt MS, Brancatif FL. Lifestyle factors, obesity and the risk of chronic kidney disease. Epidemiology. 2003;14(4):479–487
   PubMed Web of Science ®Google Scholar
• Alwakeel JS, Isnani AC, Alsuwaida A, et al. Factors affecting the progression of diabetic nephropathy and its complications: a single-Center experience in Saudi Arabia. Ann Saudi Med. 2011;31(3):236–242
   PubMedGoogle Scholar
• Coll-de-Tuero G, Mata-Cases M, Rodriguez-Poncelas A, et al. Chronic kidney disease in the type 2 diabetic patients:prevalence and associated variables in a random sample of 2642 patients of a Mediterranean area. BMC Nephrol. 2012;13:87
   PubMedGoogle Scholar
• Babayev R, Whaley-Connell A, Kshirsagar A, et al. on behalf of the KEEP Investigators. Association of Race and Body Mass Index with ESRD and Mortality in CKD Stages 3–4: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2013;61(3):404–412
   PubMedGoogle Scholar
• Fox CS, Matsushita K, Woodward M, et al. for the Chronic Kidney Disease Prognosis Consortium. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet. 2012;380:1662–1673
   PubMed Web of Science ®Google Scholar
• Brancati FL, Whittle JC, Whelton PK, Seidler AJ, Klag MJ. The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors. JAMA. 1992;268:3079–3084
   PubMed Web of Science ®Google Scholar
• Bansal N, Vittinghoff E, Plantinga L, Hsu CY. Does chronic kidney disease modify the association between body mass index and cardiovascular disease risk factors? J Nephrol. 2012;25(3):317–324
   PubMedGoogle Scholar